Quantitative CMV-antigenemia test in the diagnosis of CMV infection and in the monitoring of response to antiviral treatment in liver transplant recipients. - Suppr | 超能文献

Quantitative CMV-antigenemia test in the diagnosis of CMV infection and in the monitoring of response to antiviral treatment in liver transplant recipients.

作者信息

Lautenschlager I, Höckerstedt K, Salmela K

机构信息

Transplantation Laboratory, Helsinki University Central Hospital, Finland.

出版信息

Transplant Proc. 1994 Jun;26(3):1719-20.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Quantitative CMV-antigenemia test in the diagnosis of CMV infection and in the monitoring of response to antiviral treatment in liver transplant recipients.

Transplant Proc. 1994 Jun;26(3):1719-20.

2

Detection of CMV-DNA in peripheral blood leukocytes of liver transplant patients after ganciclovir treatment.更昔洛韦治疗后肝移植患者外周血白细胞中巨细胞病毒DNA的检测

Arch Virol. 2003 Jul;148(7):1269-74. doi: 10.1007/s00705-003-0108-7.

3

Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.异基因造血干细胞移植后巨细胞病毒再激活的监测：抗原血症检测与定量实时聚合酶链反应的比较

Bone Marrow Transplant. 2002 Apr;29(7):599-606. doi: 10.1038/sj.bmt.1703513.

4

A randomised trial comparing cytomegalovirus antigenemia assay vs screening bronchoscopy for the early detection and prevention of disease in allogeneic bone marrow and peripheral blood stem cell transplant recipients.一项随机试验，比较巨细胞病毒抗原血症检测与筛查支气管镜检查在异基因骨髓和外周血干细胞移植受者中早期检测和预防疾病的效果。

Bone Marrow Transplant. 2001 Sep;28(5):485-90. doi: 10.1038/sj.bmt.1703178.

5

Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.早期更昔洛韦治疗可有效控制病毒血症，并避免对患有巨细胞病毒血症的肾移植患者进行巨细胞病毒（CMV）预防。

Clin Transplant. 1996 Dec;10(6 Pt 1):550-5.

6

Cytomegalovirus disease after liver transplantation: diagnostics and therapy.

Transplant Proc. 1993 Aug;25(4):2673-4.

7

[Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].更昔洛韦抢先治疗对肾移植受者发生巨细胞病毒病高风险（R-/D+）的有效性

Rev Invest Clin. 2002 May-Jun;54(3):198-203.

8

Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients.人巨细胞病毒免疫逃避基因US3、US6和US11在肺移植受者血液中的表达动态

J Infect Dis. 2001 Aug 1;184(3):247-55. doi: 10.1086/322039. Epub 2001 Jul 10.

9

Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients.定量PCR在肾移植患者巨细胞病毒感染诊断及抗病毒治疗期间病毒载量监测中的应用

J Med Virol. 2005 Jul;76(3):367-72. doi: 10.1002/jmv.20367.

10

Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients.肾移植受者口服更昔洛韦预防后发生的晚期巨细胞病毒感染。

Transpl Infect Dis. 2004 Mar;6(1):3-9. doi: 10.1111/j.1399-3062.2004.00043.x.

引用本文的文献

1

Predictive value of quantitative PCR-based viral burden analysis for eight human herpesviruses in pediatric solid organ transplant patients.基于定量PCR的病毒载量分析对小儿实体器官移植患者八种人类疱疹病毒的预测价值。

J Mol Diagn. 2000 Nov;2(4):191-201. doi: 10.1016/S1525-1578(10)60637-X.